多中心尿路上皮癌克隆起源的分子生物学研究
摘要
尿路上皮癌临床常见，具有较高的多中心发生率和复发率，严重影响患者的愈后和生活质量。目前对多中心尿路上皮癌的发生机制和克隆起源尚不清楚。通过对多中心尿路上皮癌的分子生物学研究，有可能阐明多中心瘤灶的克隆关系。本文就分子生物学技术在多中心尿路上皮癌克隆起源研究进展作一综述。
出处
《国际泌尿系统杂志》
2012年第6期794-797,共4页
International Journal of Urology and Nephrology
参考文献19
-
1Harris, A. L. and Neal, D. E. Bladder cancer - field versus clon-al origin. N Engl J Med, 326: 759,1992.
-
2Hafner C, Knuechel R, Zanardo L, et al. Evidence for oligo-clonality and tumor spread by intraluminal seeding in multifocalurothelial carcinomas of the upper and lower urinary tract. One -ogene 2001,20:4910 - 4915.
-
3Hafner C,Knuechel H, Stoehr R, et al. Clonality of multifocalurothelial carcinomas : 10 years of molecular genetic studies. Int JCancer,2002,101 :1 -6.
-
4Habuchi T,Takahashi R,Yamada H,et al. Metachronus multifocaldevelopment Of urothelial cancers by intraluminal seeding cancers,1993,342; 1087 -1088.
-
5高江平,王悦增,许勇,宋涛,洪宝发,王晓雄.多发性尿路上皮肿瘤的单克隆起源[J].中华泌尿外科杂志,2002,23(1):14-15. 被引量：6
-
6Tanabe K K,Nishi T,Saya H. Novel variants of CD44 arising fromalternative splicing: changes in the CD44 alternative splicing pat-tern of MCF - 7 breast carcinoma cells treated with hyaluronidase. Mol Carcinog, 1993; 7: 212.
-
7Miyake H, Eto H, Arakawa S, et al. Over expression of CD44v8-10 in urinary exfoliated cells as an independent prognostic pre-dictor in patients with urothelial cancer. J Urol,2002 ; 167 :1282.
-
8Nagabhushan M, Pretlow T G, Guo Y J, et al. Altered expressionof CD44 in human prostate cancer during progression. Am J ClinPathol,1996,106: 647.
-
9Hideaki M,Isao H,Sadao K,et al. Multifocal transitional cell carci-noma of the bladder and upper urinary tract : molecular screeningof clonal origin by characterizing CD44 alternative splicing pat-terns, the journal of urology ,2004,172 : 1127 -1129.
-
10Sandei^ AA, Berger CS. Review of chromosome studies in uro-logical tumors. Q . Cytogenetic and molecular genetics of bladdercancer. J Urol, 1994, 151:545 -560.
二级参考文献6
-
1Adrian LH,Harris DP,David EN.Bladder cancer—field versus clonal origin[].The New England Journal of Medicine.1992
-
2Chern HD,Becich MJ,Persad RA,et al.Clonal analysis of human recurrent superficial bladder cancer by immunohistochemistry of p53 and retinoblastoma proteins[].Journal d Urologie.1996
-
3Gao JP,Uchida T,Wang CX,et al.Relationship between p53 gene mutation and protein expression: clinical significance in transitional cell carcinoma of the bladder[].International Journal of Oncology.2000
-
4Sidransky D,Frost P,von Eschenbach A,et al.Clonal origin of bladder cancer[].The New England Journal of Medicine.1992
-
5Habuchi T,Takahashi R,Yamada H,et al.Metachronus multifocal development of urothelial cancers by intraluminal seeding[].The Lancet.1993
-
6Cordon Cardo C,Dalbagni D,Saez G,e al.TP53 mutation in human bladder cancer genotypic versus phenotypic patterns[].International Journal of Cancer.1994
共引文献5
-
1曹晓明,米振国,王东文,刘春,杨晓峰.多灶性复发性表浅性膀胱移行细胞癌的克隆起源[J].肿瘤研究与临床,2006,18(1):14-15.
-
2曹晓明,米振国,王东文,刘春,杨晓峰.膀胱癌的克隆起源分析[J].山西医科大学学报,2006,37(2):153-156.
-
3王官峰(综述),李泉林(审校).多中心尿路上皮肿瘤克隆起源的研究进展[J].国际泌尿系统杂志,2011,31(3):380-382.
-
4张金刚,孙光,刘晓强,王一,冯涛.非肌层浸润性膀胱癌合并后尿道癌的电切治疗[J].中国内镜杂志,2011,17(8):883-885. 被引量：10
-
5龚书榕,陈文榜,陈梓甫,何延瑜.膀胱癌相关尿道癌的诊疗分析(附11例报告)[J].福建医药杂志,2003,25(1):32-34.
-
1诸强,陈如章,倪兆敏,卢立标.尿道巨大恶性淋巴瘤一例[J].中华放射学杂志,2000,34(3):216-216.
-
2王官峰(综述),李泉林(审校).多中心尿路上皮肿瘤克隆起源的研究进展[J].国际泌尿系统杂志,2011,31(3):380-382.
-
3郁宝铭,赵任.大肠癌分子生物学研究的现状[J].世界华人消化杂志,1999,7(2):173-175. 被引量：13
-
4郑唯强,詹镕洲.乳腺癌分子生物学研究的进展[J].肿瘤防治研究,1994,21(2):128-128.
-
5陈玉泉,陈莉.乳腺癌的分子生物学研究及临床意义[J].外科,1997,2(2):110-113.
-
6田道锋.脑膜瘤分子生物学研究[J].中国临床神经外科杂志,2000,5(3):191-191.
-
7王共先,熊礼生,唐金明.尿道腺瘤(附3例报告并文献复习)[J].临床泌尿外科杂志,1995,10(3):134-136. 被引量：2
-
8陈蔚蔚,周宏远.端粒酶的分子生物学研究进展[J].肿瘤防治研究,2000,27(4):314-316. 被引量：2
-
9Gokc.,E,章咏棠.根治性膀胱列腺切除术后尿道肿瘤复发—有无指征作...[J].德国医学,1990,7(3):158-160.
-
10王晨宇,李九智,陈茹,罗勇,文彬.吉西他滨联合顺铂方案治疗晚期尿路上皮癌的临床观察[J].国际泌尿系统杂志,2013,33(3):347-350. 被引量：1
